IBER.WS
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
IBER.WS
Delisted
IBER.WS was delisted on the 15th of February, 2023.
37 hedge funds and large institutions have $2.08M invested in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.
Holders
37
Holders Change
+4
Holders Change %
+12.12%
% of All Funds
0.63%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
6
Increased
1
Reduced
4
Closed
2
Calls
$2.22M
Puts
–
Net Calls
+$2.22M
Net Calls Change
-$2K
Top Buyers
1 |
KL
1
KIM LLC
Wichita,
Kansas
|
$16K |
2 |
CS
2
Clear Street
New York
|
$14K |
3 |
EFI
3
EHP Funds Inc
Toronto,
Canada
|
$8K |
4 |
CAC
4
Cowen and Company
New York
|
$17K |
5 |
AGM
5
Alpine Global Management
New York
|
$5K |